487 articles in this topic
Simple blood tests detecting microRNAs show promise for early prostate cancer detection, replacing painful biopsies with precision monitoring.
New EUS techniques enable liquid biopsies, AI-assisted diagnosis, and personalized therapy testing for pancreatic and liver diseases.
ROME trial shows liquid biopsies can effectively guide personalized cancer therapy, potentially replacing invasive tissue biopsies.
Revolutionary liquid biopsy technology uses nanoparticles to detect cancer biomarkers in blood with exceptional precision.
Researchers discover why combining chemotherapy with immunotherapy works better and identify a key resistance mechanism.
Despite decades of research, blood tests for early pancreatic cancer detection remain elusive due to fundamental biological barriers.
New liquid biopsy using exosomes could revolutionize screening for colorectal cancer in people under 50, when traditional screening isn't recommended.
Combining chemotherapy with immunotherapy before surgery significantly increases complete response rates in early-stage lung cancer patients.
Scientists discover ALPK1 receptor agonists trigger powerful anti-tumor immunity, offering new immunotherapy approach beyond current treatments.
Breakthrough therapy converts tumor cells into antigen-presenting cells that train immune system to destroy cancer.
New review reveals HPV causes 60-70% of throat cancers in developed countries, with survival rates varying dramatically by cancer type.
Advanced gastric cancer treatments using immunotherapy and targeted drugs extend survival by 3-4 months beyond traditional chemotherapy.
